Comparison of iopamidol with three other contrast media in orbital venography/cavernous sinography.
D002426:Cavernous Sinus / Q000000981:diagnostic imaging*; D003287:Contrast Media / Q000009:adverse effects*; D006801:Humans; D007451:Iodamide / Q000009:adverse effects; D007479:Iopamidol; D007482:Iothalamate Meglumine / Q000009:adverse effects; D007483:Iothalamic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D008793:Metrizamide / Q000009:adverse effects; D009915:Orbit / Q000098:blood supply / Q000000981:diagnostic imaging*; D010146:Pain / Q000139:chemically induced; D010690:Phlebography
D003287:Contrast Media; D007483:Iothalamic Acid; D007451:Iodamide; D007479:Iopamidol; D008793:Metrizamide; D007482:Iothalamate Meglumine